Identification of endocannabinoids and cannabinoid CB1 receptor mRNA in the pituitary gland

Neuroendocrinology

Volumn 70, Issue 2, 1999, Pages 137-145

  González, Sara ^d   Manzanares, Jorge ^d   Berrendero, Fernando ^d   Wenger, Tibor ^a   Corchero, Javier ^d   Bisogno, Tiziana ^b   Romero, Julián ^d   Fuentes, José A ^d   Di Marzo, Vincenzo ^b   Ramos, José A ^d   Fernández Ruiz, Javier J ^c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b CNR   (Italy)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d NONE

Author keywords

2 Arachidonoyl glycerol; Anandamide; Anterior pituitary; Cannabinoid receptors; Cannabinoids

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; ADENOHYPOPHYSIS HORMONE; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; DRONABINOL; LIGAND; MESSENGER RNA;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; BRAIN REGION; CONTROLLED STUDY; HORMONE RELEASE; HYPOPHYSIS; HYPOPHYSIS INTERMEDIATE LOBE; HYPOTHALAMUS; HYPOTHALAMUS VENTROMEDIAL NUCLEUS; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PRECURSOR; PRIORITY JOURNAL; RAT; RECEPTOR BINDING;

ANIMALS; AUTORADIOGRAPHY; CANNABINOIDS; CYCLOHEXANOLS; ENDOCANNABINOIDS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; IN SITU HYBRIDIZATION; MALE; PITUITARY GLAND; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RNA, MESSENGER; TETRAHYDROCANNABINOL;

EID: 0342841135     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054468     Document Type: Article

References (48)

1. 9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combination, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat. Neuroendocrinology 1990;52:316-321.
2. Murphy LL, Steger RW, Bartke A: Psychoactive and non-psychoactive cannabinoids and their effects on reproductive neuroendocrine parameters; in Watson RR (ed): Biochemistry and Physiology of Substance Abuse. Boca Raton, CRC Press, 1990, vol 2, pp 73-93.
3. 9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas. Pharmacol Biochem Behav 1992; 42:269-275.
4. 9-tetrahydrocannabinol. Neuroendocrinology 1997;65: 446-452.
5. 9-tetrahydrocannabinol exposure on adrenal medullary function: Evidence of an acute effect and development of tolerance in chronic treatments. Pharmacol Biochem Behav 1991;40:593-598.
6. 1-tetrahydrocannabinol in rats. Eur J Pharmacol 1971;14:89-92.
7. Fernández-Ruiz JJ, Muñoz RM, Romero J, Villanua MA, Makriyannis A, Ramos JA: Time-course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: Evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics. Biochem Pharmacol 1997;53:1919-1928.
8. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992;258: 1946-1949.
9. Romero J, García-Gil L, Ramos JA, Fernández-Ruiz JJ: The putative cannabinoid receptor ligand, anandamide, stimulates tyrosine hydroxylase activity and inhibits prolactin release. Neuroendocrinol Lett 1994;16:159-164.
10. Wenger T, Fragakis G, Probonas K, Toth BE, Yiannakakis N: Anandamide (endogenous cannabinoid) affects anterior pituitary hormone secretion in adult male rats. Neuroendocrinol Lett 1994;16:295-303.
11. Wenger T, Jamali KA, Juanede C, Leonardelli J, Tramu G: Arachidonyl ethanolamide (anandamide) activates the parvocellular part of hypothalamic paraventricular nucleus. Biochem Biophys Res Commun 1997;237:724-728.
12. Weidenfeld J, Feldman S, Mechoulam R: The effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamic-pituitary-adrenal axis in the rat. Neuroendocrinology 1994;59:110-112.
13. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC: Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study. J Neurosci 1991;11:563-583.
14. Howlett AC, Bidaut-Russell M, Devane WA, Melvin LS, Johnson MR, Herkenham M: The cannabinoid receptor: Biochemical, anatomical and behavioral characterization. Trends Neurosci 1990;13:420-423.
15. Mailleux P, Vanderhaeghen JJ: Distribution of neuronal cannabinoid receptors in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histo-chemistry. Neuroscience 1992;48:655-668.
16. 1-tetrahydrocannabinol on luteinizing hormone release in castrated and hypothalamic deafferented male rats. Exp Brain Res 1985;59:213-216.
17. Romero J, Wenger T, de Miguel R, Ramos JA, Fernández-Ruiz JJ: Cannabinoid receptor binding did not vary in several hypothalamic nuclei after hypothalamic deafferentiation. Life Sci 1998;63:351-356.
18. 9-tetrahydrocannabinol: Involvement of serotoninergic and dopaminergic pathways. Endocrinology 1978;103:452-458.
19. 9-tetrahydrocannabinol: Changes in hypothalamic biogenic amines and anterior pituitary hormone secretion. Neuroendocrinol Lett 1992;14:349-355.
20. 9-tetrahydrocannabinol on tuberoinfundibular dopaminergic activity, anterior pituitary sensitivity to dopamine and prolactin release vary as a function of estrous cycle. Neuroendocrinology 1993;58:280-286.
21. 9-tetrahydrocannabinol-induced stimulation of tuberoinfundibular dompaminergic activity in female rats. Biochem Pharmacol 1994;48:1387-1392.
22. 9-tetrahydrocannabinol on tuberoinfundibular dopaminergic activity and prolactin release in estrogen-replaced ovariectomized rats. Neuroendocrinol Lett 1994;16: 305-314.
23. 9-Tetrahydrocannabinol inhibits luteinizing hormone secretion in the male rat: Effect of intracerebroventricular norepinephrine infusion. Neuroendocrinol Lett 1994;16:1-7.
24. Manzanares J, Corchero J, Romero J, Fernández-Ruiz JJ, Ramos JA, Fuentes JA: Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain. Mol Brain Res 1998;55:126-132.
25. 9-Tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus. Eur J Pharmacol 1997;323:193-195.
26. de Miguel R, Romero J, Muñoz RM, García-Gil L, González S, Villanua MA, Makriyannis A, Ramos JA, Fernández-Ruiz JJ: Effects of cannabinoids on prolactin and gonadotrophin secretion: Involvement of changes in hypothalamic γ-aminobutyric acid (GABA) inputs. Biochem Pharmacol 1998;56:1331-1338.
27. 9-Tetrahydrocannabinol suppression of prolactin secretion in the rat: Lack of direct pituitary effect. Endocrinology 1981;109:876-880.
28. 9-tetrahydrocannabinol action. Pharmacol Biochem Behav 1991;40:603-608.
29. Lynn AB, Herkenham M: Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: Implications for receptor-mediated immune modulation by cannabinoids. J Pharmacol Exp Ther 1994;268:1612-1623.
30. 9-tetrahydrocannabinol. Synapse 1998;30:298-308.
31. Schmid PC, Krebsbach RJ, Perry SR, Dettmer TM, Maassen JL, Schmid HHO: Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain. FBES Lett 1995;375:117-120.
32. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates. London, Academic Press, 1986.
33. Rubino T, Massi P, Patrini G, Venier I, Giagnoni G, Parolaro D: Chronic CP-55,940 alters cannabinoid receptor-mRNA in the rat brain: An in situ hybridization study. Neuroreport 1994;5:2493-2496.
34. 35S]GTPγS binding in the basal ganglia of aged rats. Neuroscience 1998;84:1075-1083.
35. Matsuda LA, Bonner TI, Lolait SJ: Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 1993;327:535-550.
36. Jansen EM, Haycock DA, Ward SJ, Seybold US: Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Res 1992;575:93-102.
37. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992;258: 1946-1949.
38. Bisogno T, Sepe N, Melck D, Maurelli S, De Petrocellis L, Di Marzo V: Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem J 1997;322:671-677.
39. Fontana A, Di Marzo V, Cadas H, Piomelli D: Analysis of anandamide, an endogenous cannabinoid substance, and of other natural N-acylethanolamines. Prostaglandins Leukot Essent Fatty Acids 1995;53:301-308.
40. Stella N, Schweitzer P, Piomelli D: A second endogenous cannabinoid that modulates long-term potentiation. Nature 1997;388:773-778.
41. Di Marzo V, De Petrocellis L, Sepe N, Buono A: Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells. Biochem J 1996; 316:977-984.
42. Bisogno T, Berrendero F, Ambrosino G, Cebeira M, Ramos JA, Fernández-Ruiz JJ, Di Marzo V: Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem Biophys Res Commun 1999;256:377-380.
43. Corchero J, Fuentes JA, Manzanares J: Chronic treatment with CP-55,940 regulates corticotrophin-releasing factor and proopiomelanocortin gene expression in the hypothalamus and pituitary gland of the rat. Life Sci 1999;64:905-911.
44. Wenger T, Bacsy E, Jamali K, Juaneda C, Tramu G, Leonardelli J: Does the endogenous cannabinoid system play a role in the regulation of anterior pituitary hormone secretion? An in vitro study. International Cannabinoid Research Society. Symposium on the Cannabinoids, Burlington, Vt, 1998.
45. Di Marzo V: Endocannabinoids and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Biochim Biophys Acta 1998; 1392:153-175.
46. Oviedo A, Glowa J, Herkenham M: Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: A quantitative autoradiographic study. Brain Res 1993;616: 293-302.
47. 35S]GTPγS autoradiography in rat brain. J Neurosci 1996;16:8057-8066.
48. 9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions. Mol Brain Res 1997;46:100-108.